| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artiva Biotherapeutics, Inc. (ARTV) has 14 insiders with recent SEC Form 4 filings, including 4 buys and 8 sells. ARTV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 16.23M | $159.07M | +1.03M | |
| CEO | 1.54M | $15.04M | - | |
| COO | 337.9K | $3.31M | - | |
| Other | 293.4K | $2.88M | - | |
| VP | 148.2K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,027,722 | $7.44 | $7,650,148.29 | +2.2% | - | - | |
| May 19, 2026 | Banerjee Subhashis | Chief Medical Officer | Sell | 7,037 | $9.01 | $63,386.48 | -4.6% | - | - | |
| May 19, 2026 | Bush Jennifer | COO, CLO, Compliance Officer | Sell | 8,790 | $9.01 | $79,178.56 | -2.5% | - | - | |
| May 19, 2026 | Horan Christopher | Chief Tech Operations Officer | Sell | 7,002 | $9.01 | $63,072.62 | -2.3% | - | - | |
| May 19, 2026 | Raymon Heather | SVP, Research And Development | Sell | 3,095 | $9.01 | $27,879.14 | -2.0% | - | - | |
| May 19, 2026 | Aslan Fred | Chief Executive Officer | Sell | 27,116 | $9.01 | $244,252.79 | -1.7% | - | - | |
| May 11, 2026 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 6,510,416 | $11.52 | $74,999,992.32 | +74.9% | - | - | |
| Dec 15, 2025 | Aslan Fred | President And CEO | Sell | 3,187 | $6.00 | $19,122.00 | -0.3% | -1.9% | - | |
| Nov 17, 2025 | Aslan Fred | President And CEO | Sell | 6,375 | $3.38 | $21,522.00 | -1.8% | +17.1% | - | |
| Oct 17, 2025 | Aslan Fred | President And CEO | Sell | 25,500 | $6.00 | $153,000.00 | -6.7% | -25.8% | - |